Association Between Birth Weight and Risk of Pregnancy-Induced Hypertension and Gestational Diabetes in Japanese Women: JPHC-NEXT Study.


Journal

Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688

Informations de publication

Date de publication:
05 04 2022
Historique:
pubmed: 16 4 2021
medline: 9 4 2022
entrez: 15 4 2021
Statut: ppublish

Résumé

Although prevalence of low birth weight has increased in the last 3 decades in Japan, no studies in Japanese women have investigated whether birth weight is associated with the risk of pregnancy complications, such as pregnancy-induced hypertension (PIH) and gestational diabetes mellitus (GDM). We used data from the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT), a population-based cohort study in Japan that launched in 2011. In the main analysis, we included 46,365 women who had been pregnant at least once, for whom information on birth weight and events during their pregnancy was obtained using a self-administered questionnaire. Women were divided into five categories according to their birth weight, and the relationship between birth weight and risk of PIH and GDM was examined using multilevel logistic regression analyses with place of residence as a random effect. Compared to women born with birth weight of 3,000-3,999 grams, the risk of PIH was significantly higher among women born <1,500 grams (adjusted odd ratio [aOR] 1.60; 95% confidence interval [CI], 1.17-2.21), 1,500-2,499 grams (aOR 1.16; 95% CI, 1.03-1.30), and 2,500-2,999 grams (aOR 1.13; 95% CI, 1.04-1.22). The risk of GDM was significantly higher among women born 1,500-2,499 grams (aOR 1.20; 95% CI, 1.02-1.42), albeit non-significant association among women in other birthweight categories. We observed an increased risk of PIH among women born with lower birth weight albeit non-significant increased risk of GDM among Japanese women.

Sections du résumé

BACKGROUND
Although prevalence of low birth weight has increased in the last 3 decades in Japan, no studies in Japanese women have investigated whether birth weight is associated with the risk of pregnancy complications, such as pregnancy-induced hypertension (PIH) and gestational diabetes mellitus (GDM).
METHODS
We used data from the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT), a population-based cohort study in Japan that launched in 2011. In the main analysis, we included 46,365 women who had been pregnant at least once, for whom information on birth weight and events during their pregnancy was obtained using a self-administered questionnaire. Women were divided into five categories according to their birth weight, and the relationship between birth weight and risk of PIH and GDM was examined using multilevel logistic regression analyses with place of residence as a random effect.
RESULTS
Compared to women born with birth weight of 3,000-3,999 grams, the risk of PIH was significantly higher among women born <1,500 grams (adjusted odd ratio [aOR] 1.60; 95% confidence interval [CI], 1.17-2.21), 1,500-2,499 grams (aOR 1.16; 95% CI, 1.03-1.30), and 2,500-2,999 grams (aOR 1.13; 95% CI, 1.04-1.22). The risk of GDM was significantly higher among women born 1,500-2,499 grams (aOR 1.20; 95% CI, 1.02-1.42), albeit non-significant association among women in other birthweight categories.
CONCLUSIONS
We observed an increased risk of PIH among women born with lower birth weight albeit non-significant increased risk of GDM among Japanese women.

Identifiants

pubmed: 33853974
doi: 10.2188/jea.JE20200302
pmc: PMC8918619
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-173

Auteurs

Kohei Ogawa (K)

Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development.
Department of Social Medicine, National Research Institute for Child Health and Development.

Naho Morisaki (N)

Department of Social Medicine, National Research Institute for Child Health and Development.

Aurelie Piedvache (A)

Department of Social Medicine, National Research Institute for Child Health and Development.

Chie Nagata (C)

Department of Education for Clinical Research, National Center for Child Health and Development.

Haruhiko Sago (H)

Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development.

Kevin Y Urayama (KY)

Department of Social Medicine, National Research Institute for Child Health and Development.
Graduate School of Public Health, St. Luke's International University.

Kazuhiko Arima (K)

Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences.

Takayuki Nishimura (T)

Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences.

Kiyomi Sakata (K)

Department of Hygiene and Preventive Medicine, School of Medicine, Iwate Medical University.

Kozo Tanno (K)

Department of Hygiene and Preventive Medicine, School of Medicine, Iwate Medical University.

Kazumasa Yamagishi (K)

Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.
Ibaraki Western Medical Center.

Hiroyasu Iso (H)

Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.
Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Nobufumi Yasuda (N)

Department of Public Health, Kochi University Medical School.

Tadahiro Kato (T)

Center for Education and Educational Research, Faculty of Education, Ehime University.

Isao Saito (I)

Department of Public Health and Epidemiology, Oita University.

Atsushi Goto (A)

Epidemiology and Prevention Group, Center for Public Health and Sciences, National Cancer Center.

Taichi Shimazu (T)

Epidemiology and Prevention Group, Center for Public Health and Sciences, National Cancer Center.

Taiki Yamaji (T)

Epidemiology and Prevention Group, Center for Public Health and Sciences, National Cancer Center.

Motoki Iwasaki (M)

Epidemiology and Prevention Group, Center for Public Health and Sciences, National Cancer Center.

Manami Inoue (M)

Epidemiology and Prevention Group, Center for Public Health and Sciences, National Cancer Center.

Norie Sawada (N)

Epidemiology and Prevention Group, Center for Public Health and Sciences, National Cancer Center.

Shoichiro Tsugane (S)

Epidemiology and Prevention Group, Center for Public Health and Sciences, National Cancer Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH